nutriband.com (NTRB) - Market Cap to Net Income

Nutriband Inc - graphic logo of issuer NTRB

Nutriband Inc. (NTRB) business efficiency relies on transdermal drug delivery patents, where the licensing of products for fibromyalgia will be the key success factor. This chart of the current share price with the -10.80 indicator highlights the risks of FDA delays regarding opioid patches and the hypothetical return on R&D. The company's prospects depend on regulatory approval of analgesic patches and the establishment of their mass production.

nutriband.com (NTRB): Price to Earnings Ratio from 07/04/2022 to 11/16/2026

Analytical breakdowns for Nutriband Inc.

- market capitalization indicators:
General company analysis:NTRB, Nutriband Corp
Signature product of nutriband.com

The P/E ratio determines business value through the ratio of market capitalization to net income, measuring the investment payback period at the current earnings level. By analyzing the P/E value, an investor assesses the fairness of the asset's price, which for Nutriband Inc. (NTRB) is supported by operational resilience driven by diversified production and established reserves of medical materials.